In addition, MG53 has been reported to be an endogenous regulator of cardiac KChIP2 expression and Ito,f by regulating the NF-κB signalling pathway, thus playing an important role in maintaining cardiac electrical stability in hypertrophy. The gene discussed is KCNIP2; the disease is hypertrophy.